A systematic review article on the effects of FMT on obesity and MS including three randomized placebo-controlled studies with 76 patients reported that FMT improved peripheral insulin sensitivity in six weeks for patients receiving FMT compared to the placebo control. The gene discussed is INS; the disease is obesity disorder.